Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

The Effect of Schroth Exercises on Pulmonary Function in Adolescent Idiopathic Scoliosis

NCT05505695
completed

Validity and Reliability of the Turkish Version of the Pectus Carinatum Evaluation Questionnaire for Patients With Pectus Carinatum

NCT04783948
completed

Validity and Reliability of the Turkish Version of the Pectus Carinatum Body Image Quality of Life Questionnaire for Patients With Pectus Carinatum

NCT04782362
completednot_applicable

Investigation of Conservative Treatment on Adolescent Idiopathic Scoliosis Patients.

NCT04921813

Clinical Trials (4)

Showing 4 of 4 trials
NCT05505695Not Applicable

The Effect of Schroth Exercises on Pulmonary Function in Adolescent Idiopathic Scoliosis

Completed
NCT04783948

Validity and Reliability of the Turkish Version of the Pectus Carinatum Evaluation Questionnaire for Patients With Pectus Carinatum

Completed
NCT04782362

Validity and Reliability of the Turkish Version of the Pectus Carinatum Body Image Quality of Life Questionnaire for Patients With Pectus Carinatum

Completed
NCT04921813Not Applicable

Investigation of Conservative Treatment on Adolescent Idiopathic Scoliosis Patients.

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4